Hepatotoxicity induced by cyproterone acetate: A report of three cases
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Cyproterone acetate (CPA) is a steroidal synthetic progestagen and anti-androgenic compound widely administered in prostate cancer which has been evidentially correlated with a severe hepatotoxic potency. Three male patients aged 78-83 years are presented, in whom severe hepatotoxic reactions emerged after CPA administration. Patients were treated with CPA at the doses of 200-300 mg/d for malignant prostate disease for 3-12 mo prior to the acute manifestation of the hepatic disease. Clinical features compatible with mixed hepatocellular and cholestatic liver disease including jaundice, white stools and dark urine, manifested in all three cases whereas encephalopathy and ascites were present in two of the patients. Other primary causes of hepatotoxicity (alcohol consumption and viral hepatitis) were also verified in two cases, and in those patients biopsy findings revealed the presence of cirrhotic lesions in liver parenchyma. Discontinuation of the therapeutic agent led to the amelioration of the clinical profile in all the patients whereas a patient died 40 d after hospital admission due to sepsis, despite acute liver disease improvement. The current article highlights the hepatotoxic potency of a widely administered therapeutic agent and illustrates the importance of clinical surveillance especially in patients with previous hepatic diseases. Three relevant cases are reported and a review of the published literature is made.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
Severe hepatocellular dysfunction following cyproterone acetate therapy
PARYS, B. T., HAMID, S., & THOMSON, R. G. N. (1991) · British Journal of Urology · doi:10.1111/j.1464-410x.1991.tb15142.x · Cited by 39
Cyproterone acetate: hepatoxicity and prostatic cancer treatment
Roila, F., Crinò, L., Carloni, G., & Natalini, G. (1993) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058631 · Cited by 19
Cited by
Hall, A. P., Elcombe, C. R., Foster, J. R., Harada, T., Kaufmann, W., Knippel, A., Küttler, K., Malarkey, D. E., Maronpot, R. R., Nishikawa, A., et al. (2012) · Toxicologic Pathology · doi:10.1177/0192623312448935 · Cited by 427
Gava, G., Cerpolini, S., Martelli, V., Battista, G., Seracchioli, R., & Meriggiola, M. C. (2016) · Clinical Endocrinology · doi:10.1111/cen.13050 · Cited by 83
Side effects of common acne treatments
Tripathi, S. V., Gustafson, C. J., Huang, K. E., & Feldman, S. R. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.740456 · Cited by 70
In vivo study of orange peel fermentation and improvement of androgen overproduction causing acne
Yuan, Y., Zhou, J., Zhang, N., Xing, X., Zhao, L., & Zhou, F. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103124 · Cited by 8
Metadata
- Authors
- Savidou, I.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2006
- Volume
- 12
- Issue
- 46
- Pages
- 7551
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2400453670
- Cited by
- 46
- References
- 3
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatotoxicity induced by cyproterone acetate: A report of three cases. https://app.cochat.ai/papers/10.3748/wjg.v12.i46.7551
- The paper
- Savidou, I. (2006). Hepatotoxicity induced by cyproterone acetate: A report of three cases. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.v12.i46.7551
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.